Insider Transactions in Q4 2020 at Amedisys Inc (AMED)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 31
2020
|
Scott G Ginn EVP, CFO & COO |
SELL
Open market or private sale
|
Direct |
975
-5.18%
|
$279,825
$287.57 P/Share
|
Dec 31
2020
|
Scott G Ginn EVP, CFO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
975
+2.53%
|
$26,325
$27.35 P/Share
|
Dec 17
2020
|
Ivanetta Davis Samuels Director |
BUY
Grant, award, or other acquisition
|
Direct |
413
+50.0%
|
-
|
Dec 16
2020
|
Bruce D Perkins Director |
SELL
Bona fide gift
|
Direct |
210
-0.75%
|
-
|
Dec 15
2020
|
Christopher Gerard President & COO |
SELL
Open market or private sale
|
Direct |
750
-0.44%
|
$204,000
$272.38 P/Share
|
Nov 30
2020
|
Scott G Ginn EVP, CFO & COO |
SELL
Open market or private sale
|
Direct |
975
-5.18%
|
$234,975
$241.62 P/Share
|
Nov 30
2020
|
Scott G Ginn EVP, CFO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
975
+4.92%
|
$26,325
$27.35 P/Share
|
Nov 16
2020
|
Christopher Gerard President & COO |
SELL
Open market or private sale
|
Direct |
750
-0.32%
|
$183,000
$244.74 P/Share
|
Oct 30
2020
|
Scott G Ginn EVP, CFO & COO |
SELL
Open market or private sale
|
Direct |
975
-5.18%
|
$243,750
$250.0 P/Share
|
Oct 30
2020
|
Scott G Ginn EVP, CFO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
975
+2.54%
|
$26,325
$27.35 P/Share
|
Oct 18
2020
|
Scott G Ginn EVP, CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,200
-3.19%
|
$301,200
$251.67 P/Share
|
Oct 15
2020
|
Christopher Gerard President & COO |
SELL
Open market or private sale
|
Direct |
1,500
-0.83%
|
$375,000
$250.86 P/Share
|